Written question asked by Sadik Al-Hassan (Labour) on Friday, 18 July 2025, in the House of Commons. It was due for an answer on Tuesday, 22 July 2025. It was answered by Karin Smyth (Labour) on Tuesday, 12 August 2025 on behalf of the Department of Health and Social Care.
NHS: Drugs
- Question
-
To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify (a) low affordability risk and (b) strong long-term outcome data, in the context of identifying eligibility for the proportionate approach to indication-specific pricing agreements.
- Answer
-
The criteria will be developed alongside the new proportionate approach to indication-specific pricing arrangements.
Secondary information
- Type
- Written question
- Reference
- 69182
- Session
- 2024-26
- Grouped for answer
- Yes
- Subjects
- Drugs NHS Prices
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-06 13:41:49 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/69182
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/69182
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2024-25/69182